Abstract
Genomic actions of thyroid hormone require the intranuclear binding by nuclear thyroid hormone receptors (TRs) of 3,5,3’-triiodo-L-thyronine (T3). Nongenomic actions of the hormone have been described that are initiated at the plasma membrane, in cytoplasm or in the mitochondrion. These are complex processes associated with maintenance of the cytoskeleton, control of cell respiration, cell proliferation—including tumor cell proliferation and angiogenesis—and nervous system function. We briefly review here the nature of the proteins which are now appreciated to initiate nongenomic actions of the hormone when they bind T3 or L-thyroxine (T4). These receptor proteins for nongenomic effects include truncated isoforms of TRα, cytoplasmic intact TRβ, certain cytoplasmic enzymes and a structural protein of the plasma membrane, integrin αvβ3.
| Original language | English |
|---|---|
| Pages (from-to) | 94-97 |
| Number of pages | 4 |
| Journal | Immunology, Endocrine and Metabolic Agents in Medicinal Chemistry |
| Volume | 15 |
| Issue number | 1 |
| DOIs | |
| Publication status | Published - Jul 1 2015 |
UN SDGs
This output contributes to the following UN Sustainable Development Goals (SDGs)
-
SDG 3 Good Health and Well-being
Keywords
- Integrin αvβ3
- Pyruvate kinase M1
- TRΔα1
- TRα1
- TRβ
- p28 TRα1
- p43 TRα1
- μ-Crystallin
ASJC Scopus subject areas
- Endocrinology, Diabetes and Metabolism
- Immunology and Allergy
- Pharmacology
Fingerprint
Dive into the research topics of 'Receptor proteins for nongenomic actions of thyroid hormone'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS